ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORKA ORUKA THERAPEUTICS INC

交易中 07-08 13:23:25 EDT

82.48

-2.02

-2.39%

最高87.23	最低81.19	成交量51.40万
今开84.50	昨收84.50	日振幅7.15%
总市值49.75亿	流通市值45.54亿	总股本6,031万
成交额4,314万	换手率0.93%	流通股本5,522万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":82.48,"timestamp":1783531395011,"preClose":84.5,"halted":0,"volume":513992,"delay":0,"changeRate":-0.023905325443786936,"floatShares":55215667,"shares":60312101,"eps":-2.32,"marketStatus":"交易中","change":-2.02,"latestTime":"07-08 13:23:25 EDT","open":84.5,"high":87.23,"low":81.19,"amount":43143756.555392,"amplitude":0.071479,"askPrice":82.49,"askSize":101,"bidPrice":82.33,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.32,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1783540800000},"marketStatusCode":2,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":84.5,"preHourTrading":{"tag":"盘前","latestPrice":84.49,"preClose":84.5,"latestTime":"09:19 EDT","volume":1004,"amount":84680.11096,"timestamp":1783516795634,"change":-0.01,"changeRate":-0.000118,"amplitude":0.043669},"postHourTrading":{"tag":"盘后","latestPrice":84.5,"preClose":84.5,"latestTime":"18:37 EDT","volume":11973,"amount":1011689.84,"timestamp":1783463851818,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.370987,"impliedVol":0.9156,"impliedVolPercentile":0.4143},"requestUrl":"/m/hq/s/ORKA","defaultTab":"news","newsList":[{"id":"1173202228","title":"异动解读｜Oruka Therapeutics盘中上涨6.18%，瑞银看好下半年关键临床数据催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1173202228","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173202228?lang=zh_cn&edition=full","pubTime":"2026-07-08 00:57","pubTimestamp":1783443423,"startTime":"0","endTime":"0","summary":"7月8日，Oruka Therapeutics盘中上涨6.18%，报88.265美元/股，成交额1.1亿美元。消息面上，瑞银近日发布研报指出，Oruka Therapeutics核心银屑病候选药物ORKA-001下半年将公布的28周疗效数据有望进一步降低项目风险。此外，瑞银认为初步一年期持久性数据将为该药物实现半年或年度给药方案提供早期信号，预计相关更新将于第三季度末或第四季度发布。瑞银同时指出，艾伯维拟收购Apogee Therapeutics一事也验证了ORKA-001所基于的YTE平台价值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118319077","title":"异动解读｜Oruka Therapeutics盘中下跌11.21%，报82.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118319077","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118319077?lang=zh_cn&edition=full","pubTime":"2026-07-03 03:13","pubTimestamp":1783019586,"startTime":"0","endTime":"0","summary":"7月3日，Oruka Therapeutics盘中下跌11.21%，报82.83美元/股，成交额3.19亿美元。Oruka Therapeutics所在的生物科技行业中，个股中，艾伯维公司涨3.58%，Moderna涨8.52%，福泰制药涨5.07%，Abivax涨7.61%，吉利德科学涨3.44%。Oruka Therapeutics是一家临床阶段的生物制药公司，专注于开发用于治疗银屑病及其他炎症和免疫疾病的新型单克隆抗体疗法，其核心候选药物ORKA-001此前在二期a阶段临床试验中第16周数据表现积极，63.5%的患者达到完全皮肤清除的主要终点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173253469","title":"Oruka Therapeutics修正案扩展适用范围 对炎症性肠病设剂量限制","url":"https://stock-news.laohu8.com/highlight/detail?id=1173253469","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173253469?lang=zh_cn&edition=full","pubTime":"2026-06-02 04:05","pubTimestamp":1780344316,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，Oruka Therapeutics公司的一项修正案已将其药物开发领域的适用范围扩展至所有用途，但针对炎症性肠病（IBD）的应用设定了剂量限制。这一调整可能意味着该公司正在调整其核心候选药物的开发策略，旨在拓宽治疗潜力，同时针对特定疾病制定更精细的给药方案。此举通常被视为公司为优化资产价值、应对监管要求或基于最新临床数据而采取的战略步骤。投资者将关注这一变化如何影响该药物的未来临床路径和市场前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144908013","title":"奥洛兹美医疗与Oruka达成合作协议：后者将支付首付款及里程碑款项，前者享有中个位数百分比特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1144908013","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144908013?lang=zh_cn&edition=full","pubTime":"2026-05-06 20:01","pubTimestamp":1778068881,"startTime":"0","endTime":"0","summary":"奥洛兹美医疗公司宣布，其合作伙伴Oruka Therapeutics Inc.将根据双方达成的授权协议，向奥洛兹美医疗支付一笔首付款以及后续的里程碑款项。\n此外，奥洛兹美医疗还有资格获得基于Oruka相关产品未来净销售额的中个位数百分比（mid-single digit）特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HALO","LU0053671581.USD","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139318046","title":"Oruka Therapeutics公布Orka-001在中重度斑块状银屑病二期临床试验的积极第16周数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1139318046","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139318046?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:04","pubTimestamp":1777287880,"startTime":"0","endTime":"0","summary":"生物制药公司Oruka Therapeutics宣布，其核心候选药物Orka-001在针对中重度斑块状银屑病开展的Everlast二期a阶段临床试验中，第16周随访数据呈现积极结果。\n该持续进行的临床研究旨在评估Orka-001的有效性与安全性，最新数据表明，在治疗第16周时，药物在改善患者皮损严重程度方面显示出显著疗效，达到了试验预设的主要终点指标。这一进展为后续临床试验的推进提供了有力支持，也增强了市场对该疗法潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602323961","title":"Oruka Therapeutics, Inc.盘中异动 股价大跌5.03%报26.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602323961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602323961?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:23","pubTimestamp":1767896601,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日02时23分，Oruka Therapeutics, Inc.股票出现波动，股价大幅下挫5.03%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518628979","title":"Oruka Therapeutics, Inc.2024财年实现净利润-83.72百万美元，同比减少1467.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518628979?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536084,"startTime":"0","endTime":"0","summary":"3月10日，Oruka Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-83.72百万美元，同比减少1467.79%；其中营业收入为0.00美元，每股基本收益为-4.99美元。机构评级：截至2025年3月10日，当前有7家机构对Oruka Therapeutics, Inc.目标价做出预测，其中目标均价为39.86美元，其中最低目标价为20.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000310a268989d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000310a268989d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517147141","title":"Oruka Therapeutics(ORKA.US)：2024年Q4财报实现营收0美元；每股收益为-0.49美元，预期值为-0.98美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147141","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147141?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:03","pubTimestamp":1741302186,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics(ORKA.US)：2024年Q4财报实现营收0美元；每股收益为-0.49美元，预期值为-0.98美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070348578859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORKA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179465603","title":"Oruka Therapeutics 2024年第四季度GAAP每股收益$(0.49)优于$(0.79)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1179465603","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179465603?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:26","pubTimestamp":1741296399,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics（LENZ）2024年第四季度GAAP每股收益为$(0.49)，优于$(0.79)的市场预期。以上内容来自Benzinga Earnings专栏，原文如下：Oruka $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.49) Beats $(0.79) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514830378","title":"Oruka Therapeutics, Inc.盘中异动 早盘大幅拉升6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514830378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753080,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速上涨6.54%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.35%、239.11%、55.70%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223120abe0ea11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223120abe0ea11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514988332","title":"Oruka Therapeutics, Inc.盘中异动 股价大跌5.03%报10.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514988332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514988332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:20","pubTimestamp":1740687649,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时20分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报10.00美元/股，成交量24.6738万股，换手率0.70%，振幅7.12%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042050abdfbab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042050abdfbab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509466097","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509466097?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685753,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分，Oruka Therapeutics, Inc.股票出现波动，股价快速拉升5.40%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1630.09%、925.32%、453.14%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001553a2393cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001553a2393cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507678187","title":"Oruka Therapeutics, Inc.盘中异动 急速上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507678187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507678187?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:05","pubTimestamp":1738253124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时05分，Oruka Therapeutics, Inc.股票出现异动，股价大幅上涨5.97%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1600.16%、212.94%、197.28%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100052496144847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100052496144847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORKA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271998","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271998?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:31","pubTimestamp":1737469889,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速拉升5.96%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Dogwood Therapeutics, Inc.、Replimune Group, Inc.、Allakos Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为515.43%、161.03%、26.98%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Allakos Inc.、Equillium, Inc.，振幅分别为140.64%、111.05%、107.00%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。它为患有斑块状牛皮癣等慢性皮肤病的患者提供服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223129986e32c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223129986e32c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503188019","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大涨6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503188019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503188019?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:31","pubTimestamp":1737037918,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时31分，Oruka Therapeutics, Inc.股票出现波动，股价快速上涨6.26%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Cytomed Therapeutics Limited涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为976.84%、334.72%、194.06%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Aditxt, Inc.、Onconetix, Inc.，振幅分别为21.79%、12.06%、9.03%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223158a2245fa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223158a2245fa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500112689","title":"Oruka Therapeutics, Inc.盘中异动 早盘快速下挫7.86%报18.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500112689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500112689?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:30","pubTimestamp":1735914659,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时30分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌7.86%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为843.25%、450.51%、254.33%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.、Oculis Holding Ag C/Wts 06/03/2028 ，振幅分别为20.87%、14.34%、7.60%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010322305995f7d19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010322305995f7d19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491328375","title":"Oruka Therapeutics, Inc.盘中异动 大幅拉升5.07%报22.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491328375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491328375?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:34","pubTimestamp":1734100489,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时34分，Oruka Therapeutics, Inc.股票出现异动，股价急速拉升5.07%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Barinthus Biotherapeutics Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为26.10%、21.62%、16.58%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Oculis Holding Ag C/Wts 06/03/2028 、Innate Pharma，振幅分别为30.24%、20.93%、19.35%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322345095e976d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322345095e976d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486494886","title":"Oruka Therapeutics, Inc.盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486494886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486494886?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:47","pubTimestamp":1732639644,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时47分，Oruka Therapeutics, Inc.股票出现异动，股价快速上涨5.73%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为42.96%、29.76%、24.03%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Protagenic Therapeutics, Inc.，振幅分别为85.82%、57.50%、42.94%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127004725971a8afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127004725971a8afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486803167","title":"Oruka Therapeutics, Inc.盘中异动 早盘股价大跌6.00%报19.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486803167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486803167?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:05","pubTimestamp":1732550751,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时05分，Oruka Therapeutics, Inc.股票出现波动，股价急速下跌6.00%。截至发稿，该股报19.51美元/股，成交量9.8042万股，换手率0.28%，振幅7.98%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600055198e44747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600055198e44747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485829872","title":"Oruka Therapeutics, Inc.2024财年第三财季实现净利润-28.62百万美元，同比减少1915.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485829872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485829872?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291303,"startTime":"0","endTime":"0","summary":"11月23日，Oruka Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.62百万美元，同比减少1915.49%；其中营业收入为0.00美元，每股基本收益为-1.91美元。机构评级：截至2024年11月23日，当前有6家机构对Oruka Therapeutics, Inc.目标价做出预测，其中目标均价为43.17美元，其中最低目标价为40.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000203a24e490b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000203a24e490b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.orukatx.com","stockEarnings":[{"period":"1week","weight":-0.1121},{"period":"1month","weight":0.4051},{"period":"3month","weight":0.3627},{"period":"6month","weight":2.2008},{"period":"1year","weight":5.3582},{"period":"ytd","weight":1.7879}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oruka Therapeutics, Inc.于1992年在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发用于治疗银屑病及其他炎症和免疫疾病的新型单克隆抗体疗法。公司运用抗体工程和制剂创新技术，结合已验证的作用机制，旨在提高现有标准疗法的疗效和给药方案，同时降低技术和生物学风险。其研发项目旨在通过靶向疾病病理机制和致病性组织驻留记忆 T 细胞的活性，治疗并可能改善疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":0.043718},{"month":2,"riseRate":0.388889,"avgChangeRate":-0.070079},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.00265},{"month":4,"riseRate":0.611111,"avgChangeRate":0.112851},{"month":5,"riseRate":0.5,"avgChangeRate":0.08077},{"month":6,"riseRate":0.333333,"avgChangeRate":0.460115},{"month":7,"riseRate":0.5,"avgChangeRate":0.018032},{"month":8,"riseRate":0.117647,"avgChangeRate":-0.132304},{"month":9,"riseRate":0.352941,"avgChangeRate":-0.05799},{"month":10,"riseRate":0.470588,"avgChangeRate":-0.023177},{"month":11,"riseRate":0.647059,"avgChangeRate":0.007168},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.002826}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ORUKA THERAPEUTICS INC(ORKA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ORUKA THERAPEUTICS INC,ORKA,ORUKA THERAPEUTICS INC股票,ORUKA THERAPEUTICS INC股票老虎,ORUKA THERAPEUTICS INC股票老虎国际,ORUKA THERAPEUTICS INC行情,ORUKA THERAPEUTICS INC股票行情,ORUKA THERAPEUTICS INC股价,ORUKA THERAPEUTICS INC股市,ORUKA THERAPEUTICS INC股票价格,ORUKA THERAPEUTICS INC股票交易,ORUKA THERAPEUTICS INC股票购买,ORUKA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ORUKA THERAPEUTICS INC(ORKA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ORUKA THERAPEUTICS INC(ORKA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}